Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, February 24, 2021
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
[ Wed, Feb 24th 2021
] - WOPRAI
Geoffrey Porges Maintained (TBPH) at Buy with Increased Target to $41 on, Feb 24th, 2021
Geoffrey Porges of SVB Leerink, Maintained "Theravance Biopharma, Inc." (TBPH) at Buy with Increased Target from $35 to $41 on, Feb 24th, 2021.
Geoffrey has made no other calls on TBPH in the last 4 months.
There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with Geoffrey's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Geoffrey
- Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $31 on, Wednesday, December 16th, 2020
- Liisa Bayko of "Evercore ISI Group" Initiated at Buy and Held Target at $30 on, Tuesday, November 24th, 2020
